A systematic review of LDL apheresis in the treatment of cardiovascular disease
- 21 March 2006
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 189 (1) , 31-38
- https://doi.org/10.1016/j.atherosclerosis.2006.02.030
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- MANAGEMENT OF HYPERCHOLESTEROLEMIAMedical Clinics of North America, 2000
- Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemiaThe American Journal of Cardiology, 1998
- Safety and effectiveness of long‐term LDL‐apheresis in patients at high riskCurrent Opinion in Lipidology, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatmentsThe American Journal of Cardiology, 1995
- Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapyAtherosclerosis, 1995
- The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease.European Journal of Clinical Investigation, 1991
- An Overview of Lipid-Lowering DrugsDrugs, 1988
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975